 JERUSALEM, Nov. 15, 2021 PRNewswire -- BiondVax Pharmaceuticals Ltd. Nasdaq: BVXV, which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, announced today that Chief Executive Officer Amir Reichman will present a company overview at the H.C. 